Wall Street analysts changed outlook on top names. Wedbush raised Replimune's price target, Cana

BTIG analyst Marie Thibault maintains Edwards Lifesciences (NYSE:EW) with a Buy and raises the pr

NEW YORK--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) today announced new data presented at New

CMS proposes easing TAVR coverage rules and expanding access, a move analysts say could strengthen E

RBC Capital analyst Shagun Singh reiterates Edwards Lifesciences (NYSE:EW) with a Outperform and

TD Cowen analyst Joshua Jennings maintains Edwards Lifesciences (NYSE:EW) with a Buy and raises t

Barclays analyst Matt Miksic maintains Edwards Lifesciences (NYSE:EW) with a Overweight and raise

Edwards Lifesciences shares rise after Q1 earnings beat, with strong valve therapy growth and update

Evercore ISI Group analyst Vijay Kumar maintains Edwards Lifesciences (NYSE:EW) with a Outperform

Truist Securities analyst Richard Newitter maintains Edwards Lifesciences (NYSE:EW) with a Hold a

Canaccord Genuity analyst William Plovanic maintains Edwards Lifesciences (NYSE:EW) with a Hold a

BTIG analyst Marie Thibault maintains Edwards Lifesciences (NYSE:EW) with a Buy and raises the pr

Baird analyst David Rescott maintains Edwards Lifesciences (NYSE:EW) with a Neutral and raises th

Edwards Lifesciences (NYSE:EW) is looking for Q2 Adj EPS of $0.70-$0.76 vs $0.75 analyst estimate. s

Edwards Lifesciences (NYSE:EW) raises FY2026 Adj EPS guidance from $2.90-$3.05 to $2.95-$3.05 vs $2.

Edwards Lifesciences (NYSE:EW) reported quarterly earnings of $0.78 per share which beat the analyst

Evercore ISI Group analyst Vijay Kumar maintains Edwards Lifesciences (NYSE:EW) with a Outperform

Edwards Lifesciences (NYSE: EW) today announced new data on the EVOQUE transcatheter tricuspid valve

Penumbra (PEN) climbs on strong Q4 results and acquisition agreement with Boston Scientific (BSX), d

Andreas Halvorsen of Viking Global Investors' portfolio Q3 changes included exits from Amazon, N

Tech stocks edged higher Friday, rebounding from Thursday's 1.5% drop in the Nasdaq 100 as upbea

Wall Street saw a cautious tone on Thursday as major tech-heavy indexes edged lower, weighed down by

Performance Food rejects offer; Lufthansa drops Air Europa bid; NFL inks deal with ESPN; Claire'

Wall Street looked set to close the week on a high note, with large-cap benchmarks pushing higher in

U.S. equities are pushing higher for a third straight session, eyeing the longest winning streak sin

Risk-on sentiment dominated Wall Street on Wednesday, as upbeat earnings reports and conciliatory me

A hotter-than-expected inflation report initially rattled markets on Wednesday morning, but investor

U.S.

Morgan Stanley upgrades key MedTech stocks, highlighting strong demand and growth potential, while d

Tech stocks outperformed on Thursday, driven by Tesla Inc. (NASDAQ:TSLA), which skyrocketed 18% in m

The stock rally that propelled the S&P 500 and the Dow to record highs last week seems to have s

Companies Reporting Before The Bell • BP (NYSE:BP) is projected to report quarterly earnings at $1.

Companies Reporting Before The Bell • Deutsche Bank (NYSE:DB) is estimated to report quarterly earn

Gainers Femasys Inc. (NASDAQ: FEMY) gained 54% to $0.55. Femasys reported a notice of allowance f